Status:
COMPLETED
A Dyadic Approach for a Remote Physical Activity Intervention in Adults With AD and Their Caregivers
Lead Sponsor:
University of Kansas
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The objective of this study is to compare the effectiveness of 2 intervention delivery strategies for increasing moderate physical activity (MPA), real-time group video conferencing (RGV) vs. enhanced...
Detailed Description
This study will compare 2 strategies for the delivery of an intervention to increase moderate physical activity (MPA) in community dwelling adults with AD and their caregiver (dyads); real-time group ...
Eligibility Criteria
Inclusion
- Adults with AD -
- Very mild to moderate dementia
- Age ≥ 55 yrs
- Low-risk of falls
- Ability to participate in MPA, e.g., walk including with an assistive device, as verified PCP clearance.
- Ability to communicate verbally.
- Vision and hearing sufficient to safely comply with the intervention program as verified by PCP clearance.
- Reside at home and receive support from a caregiver.
- Internet access in the home.
- Caregivers-
- Age ≥18 yrs.
- Spends at least 20 hrs./wk. with the adult with AD.
Exclusion
- Adults with AD-
- Current exercise, i.e., \> 3, 30-min bouts of planned exercise/wk.
- Clinically significant psychiatric disorder; systemic illness or infection likely to affect safety; clinically-evident stroke; myocardial infarction or coronary artery disease in the last 2 yrs.; cancer in the last 5 yrs.; or significant pain or musculoskeletal symptoms that would prohibit exercise.
- Unwilling to be randomized.
- Caregivers-
- Unable to participate in MPA, i.e., brisk walking.
- Unwilling to be randomized.
- Serious medical risk, such as cancer within the last 5 yrs. or cardiac event, i.e., heart attack, stroke, angioplasty within the last 2 yrs.
Key Trial Info
Start Date :
July 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2024
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT04102514
Start Date
July 6 2020
End Date
August 19 2024
Last Update
June 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas
Lawrence, Kansas, United States, 66045